Here is a description of Source BioScience from the company website:
With over 15 years of Sanger sequencing experience, the service operates from state of the art facilities in Nottingham, Cambridge, Oxford, Rochdale and BioCity Scotland, with European facilities in Ireland and Germany. The sequencing service provides unique benefits for the customer including an Overnight service, easy online ordering and SpeedREAD automated data delivery.
Complimenting this, the next generation sequencing service for life science research, molecular pathology and clinical diagnostics utilises the Illumina MiSeq™ and HiSeq™ platforms to provide the most comprehensive and advanced service from GLP/GCP accredited laboratories.
Contract research services feature a broad range of microarray, genotyping and gene expression applications on Affymetrix, Agilent, and Fluidigm platforms.
An extensive product portfolio includes over 20 million clones and over 200,000 antibodies, plus a wide range of research reagents for use in applications such as cell culture, immunology, nucleic acid analysis and cloning, gene expression and regulation.
Source BioScience can offer researchers in academia and in the pharmaceutical industry the highest quality resources and innovative technology with maximum flexibility and cost effectiveness.
No doubt further announcements will be forthcoming in due course. It will be interesting to see what the company's plans are for the various Moffat Partnership websites.
©2016 Debbie Kennett